MLAB (Mesa Laboratories) Total Liabilities : $281.9 Mil (As of Dec. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Mesa Laboratories Total Liabilities?

Mesa Laboratories's Total Liabilities for the quarter that ended in Dec. 2024 was $281.9 Mil.

Mesa Laboratories's quarterly Total Liabilities increased from Jun. 2024 ($289.63 Mil) to Sep. 2024 ($292.65 Mil) but then declined from Sep. 2024 ($292.65 Mil) to Dec. 2024 ($281.93 Mil).

Mesa Laboratories's annual Total Liabilities declined from Mar. 2022 ($313.57 Mil) to Mar. 2023 ($268.35 Mil) but then increased from Mar. 2023 ($268.35 Mil) to Mar. 2024 ($301.40 Mil).

Mesa Laboratories Total Liabilities Historical Data

The historical data trend for Mesa Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesa Laboratories Total Liabilities Chart

Mesa Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

189.10

195.25

313.57

268.35

301.40

Mesa Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															338.81	301.40	289.63	292.65	281.93

Mesa Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Mesa Laboratories's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	44.312	+	(221.698	+	15.613
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	19.78	+	0	+	0)
	=	301.4

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	446.796	-	145.393
	=	301.4

Mesa Laboratories's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	155.878	+	(107.164	+	0.092000000000038
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	18.8	+	0	+	0)
	=	281.9

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	437.148	-	155.214
	=	281.9

Mesa Laboratories Total Liabilities Related Terms

Thank you for viewing the detailed overview of Mesa Laboratories's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mesa Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Mesa Laboratories Inc (NAS:MLAB) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

MLI:Germany

Address

12100 West Sixth Avenue, Lakewood, CO, USA, 80228

Website

https://www.mesalabs.com

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Executives

Gary M Owens	officer: COO	12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Brian David Archbold	officer: SVP of Continuous Improvement	12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John Bradley Schmieder	director	C/O MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John V Sakys	officer: VP Finance, CFO	MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Shannon Hall	director	1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Evan Guillemin	director	380 LAFAYETTE STREET, SIXTH FLOOR, NEW YORK NY 10003
R Tony Tripeny	director	ONE RIVERFRONT PLAZA, CORNING NY 14831
Gregory Dinoia	officer: SVP Commercial Operations	12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Mesa Laboratories Inc /co/	director	12100 W 6TH AVE, LAKEWOOD CO 80228
John James Sullivan	officer: VP Sales & Marketing	12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David M Kelly	director
Shiraz Shabanali Ladiwala	director	C/O THERMO FISHER SCIENTIFIC INC., 168 THIRD AVENUE, WALTHAM MA 02451
Robert V Dwyer	director	12100 W 6TH AVE, LAKEWOOD CO 80228
Jennifer Sadie Alltoft	director	12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David Brian Perez	director	12100 6TH AVENUE, LAKEWOOD CO 80228